Research: Evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and the Life Sciences Innovative Manufacturing Fund
Safety Classified by Officially
Findings from the early‑stage evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and its successor, the Life Sciences Innovative Manufacturing Fund.
The funds provided capital grants to support life sciences manufacturing projects in the UK, with objectives including strengthening domestic manufacturing capability, supporting economic growth and enhancing health resilience.
The evaluation was commissioned by the Office for Life Sciences and delivered by Ipsos, covering Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) and Life Sciences Innovative Manufacturing Fund (LSIMF) projects funded through the 2021 and 2022 calls for proposals.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/publications/evaluation-of-the-medicines-and-diagnostics-manufacturing-transformation-fund-and-the-life-sciences-innovative-manufacturing-fund
Officially imported this from Office for Life Sciences’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Office for Life Sciences — imported from official source
- Official source
- https://www.gov.uk/government/organisations/office-for-life-sciences.atom ATOM
- Imported
- September 20, 2026 21:00
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/publications/evaluation-of-the-medicines-and-diagnostics-...